The Latest

Press Releases FDA

For Immediate Release: August 7, 2018
Information for the media: Gloria Sanchez , 301-796-7686
Consumer information: 888-INFO-FDA
Dr. Scott Gottlieb statement, FDA commissioner, on efforts to protect the health of women misleading statements and considerable health risks related to devices marketed for use in medical interventions “vaginal rejuvenation”
July 30, 2018 – Recently, we learned of a growing number of manufacturers who market devices “vaginal rejuvenation” for women, stating that these procedures treat conditions and symptoms related to menopause, urinary incontinence or sexual function. Interventions make use of lasers and other devices that use energy to destroy or reconfigure the vaginal tissue. These products carry serious risks and lack sufficient evidence to support its use for these purposes. We are extremely worried that it is causing harm to women.

Dr. Scott Gottlieb statement, FDA commissioner, on voluntary product recall Ritz andGoldfish, among others, as a precaution
July 24, 2018 – The FDA is collaborating with Mondelez International, Inc., Pepperidge Farm Inc. andFlowers Foods, Inc. to launch the voluntary recall of certain products because of the potential risk that one of its ingredients may be contaminated with Salmonella. Food in question include various cheese sandwiches the Ritz brand and cheese products brand Ritz Bits Mondelez, certain cookies Goldfishbrand Pepperidge Farm, and Swiss pastries Rolls of Flowers Foods, sale using different brands. On our Web site you will find additional information about each specific product called retirement. We encourage people to discard or return any affected product to the store where they bought it .

Dr. Scott Gottlieb statement, FDA Commissioner, on the announcement of the manufacturer stopped selling the Essure in the United States; dependence reaffirms its commitment to assess the Essure after marketing and keep women informed
July 20, 2018 – Bayer notified the Food and Drug Administration US (FDA, for its acronym in English) that the device permanent contraception Essure will no longer be sold or distributed after December 2018. 31 This decision he took after the action taken by the FDA in April to protect the safety of patients, in which the dependence issued an order restricting the sale and distribution of Essure; It was a special type of restriction on the FDA exercised its authority to impose additional requirements in order to provide reasonable assurance of safety and effectiveness for the device.

FDA statement warning about the significant health risks posed by contaminated synthetic cannabinoids illegal products that are finding dependence
July 19, 2018 – The FDA has learned reports of serious illness and death due to consumption productssynthetic cannabinoids (marijuana) contaminated with brodifacoum, an anticoagulant very long – acting commonly used in rat poisons. These unsanctioned products are sold in convenience stores and gas stations as substitutes for marijuana, with names such as “K2” and “Spice”. Consumption of these illegal products raises concerns of significant public health for both people who could consume contaminated to the blood supply in the United States products, since there is a possibility that blood products donated by those who have used these substances are contaminated.

FDA warning against impostors who are sending false letters of warning to consumers
July 13, 2018 – The Food and Drug Administration US (FDA, for its acronym in English) is warning consumers about offenders who are faking warning letters from the FDA to prey on people who tried to buy drugs online or by phone.

The FDA announced the voluntary recall of several drugs containing valsartan, following the detection of an impurity
July 13, 2018 – The Food and Drug Administration US (FDA, for its acronym in English) is alerting patients and health professionals on a voluntary recall of several drugs containing the active ingredientvalsartan, which is used to treat hypertension, and heart failure


The FDA, an agency   Department of Health and Human Services of the United States protects public health by ensuring the integrity, efficiency and security of human and veterinary drugs, vaccines and other biological products for human use and medical devices. The agency is also responsible for the safety and security of food supply of our nation, cosmetics, dietary supplements, products that give off electronic radiation, and regulate snuff products.

Leave a comment

Your email address will not be published.


wp ecommerce - e-commerce wordpress